FROM THE EDITOR-IN-CHIEF CAR-T Cells: ‘Bionic’ Immune Cells for Treating Cancer T cells are being rebuilt to kill cancer cells. by William G. Nelson, MD, PhD Predicting Acute Myeloid Leukemia Two studies identify genetic mutations that could predict the risk of an aggressive blood cancer up to a decade before it is diagnosed. by Anna Azvolinsky Challenges Remain for Kids With Cancer More children are being treated successfully for cancer. Yet researchers continue searching for new therapies that will help kids who don't respond to standard treatments. by Cameron Walker Survivor Profile Putting Her Armor On An acute myeloid leukemia survivor and former TV news reporter finds a new reason to help others improve their health. by Jennifer Walker Treatment Is Waiting For patients with chronic blood cancers, the early intervention mantra of cancer does not always apply. by Sue Rochman Yesterday & Today Improbable Champion Susan Butcher won Alaska's grueling Iditarod dog-sled race four times. Her 2005 leukemia diagnosis marked the beginning of her greatest challenge. by Jocelyn Selim Yesterday & Today Shining a Light 60 Minutes journalist Ed Bradley tried to “shine a light in a dark corner” through his work, but he kept his long struggle with chronic lymphocytic leukemia private. by Brittany Moya del Pino Forward Look When the Cancer Doctor Gets Cancer Q & A with breast surgeon Susan Love on her new role: cancer survivor. by Betty Russell The Power of One A cancer survivor reflects on the stranger who gave him a second chance at life. by Robert Henslin Cancer Talk Considering the Term “Cancer Survivor” A study investigates how people who have been diagnosed with cancer feel about being called survivors. by Jen Tota McGivney Making Clinical Trials More Inclusive Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment. by Ashley P. Taylor What Do Clinical Trial Endpoints Really Measure? A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life. by Jon Kelvey Shingles Risk Increased for Cancer Patients A new vaccine is safe for cancer patients but hard to find. by Nancy Averett More Posts